Trials / Completed
CompletedNCT00004404
Study of Clotrimazole and Hydroxyurea in Patients With Sickle Cell Syndromes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Boston Children's Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
OBJECTIVES: Determine the effectiveness of the combined use of clotrimazole and hydroxyurea on a specific panel of red cell characteristics in patients with sickle cell syndromes.
Detailed description
PROTOCOL OUTLINE: Patients receive oral hydroxyurea either once or twice daily plus oral clotrimazole twice daily after meals for 6 months. Patients are assessed at 3 and 6 months during treatment. Completion date provided represents the completion date of the grant per OOPD records
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | clotrimazole | |
| DRUG | hydroxyurea |
Timeline
- Start date
- 1997-04-01
- Completion
- 2002-09-01
- First posted
- 1999-10-19
- Last updated
- 2015-03-25
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00004404. Inclusion in this directory is not an endorsement.